Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
This role is fully based in Dubai Para una comprensión completa de esta oportunidad y de lo que se requerirá para ser un candidato exitoso, siga leyendo. - RELOCATION TO DUBAI (Relocation support provided). We are